METHOD FOR DETECTING TUMOR RISK GROUP AND MAKING EARLY STAGE TUMOR DISEASE CASES SCREENING Russian patent published in 1999 - IPC

FIELD: medicine. SUBSTANCE: method involves introducing oncopathogenically valid tests only into complex (like Bolen test, Korotkoruchko test, fluorescence test, aspirin test and peroxide hemolysis erythrocyte response). Each test contribution into the general result is evaluated by differentiating diagnostic sensibility and specificity of a test under studied using computer nomogram treatment of the results obtained. Bolen test result being greater than 10 units, peroxide hemolysis erythrocyte response being less than 0.5 units or greater than 0.8 units, aspirin test result being greater than 15 units, Korotkoruchko test result being greater than 7 units, fluorescence test result being greater than 0.7 units, tumor risk group is considered to be detected and early stage tumor disease case screening is to be carried out. EFFECT: enhanced effectiveness in building projections of hardly accessible neoplasm formations during patient life time to enable development of surgical access to the formations to be accurate. 2 dwg, 2 tbl